
Editorial JHVEPhoto/iStock via Getty Images
Zoetis shares (NYSE:ZTS) traded lower on Tuesday after the US FDA notified veterinarians of adverse events related to the company’s pain therapy, Librela (bedinvetmab injection), indicated for dogs.
In a “Dear Veterinarian” letter Monday, the agency noted that adverse events like





